Company Profile
GC is a biotechnology company. The company provides prescription drugs and over-the-counter drugs. Its portfolio also includes aseptic fill and finish services for drug manufacturing, and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency.
Its portfolio also includes vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella, recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome, and small molecules for gangliosidosis andalagille's syndrome.
The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials Personalized nutrition injections. Founded in 1967 and headquartered in Yongin-Si, South Korea, the company was formerly known as Green Cross Holdings Corporation before rebranding in April 2026.